Lamisil AT by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Drug facts, warnings, and ingredients follow.
|
NDC: 0067-8100-30
TERBINAFINE HYDROCHLORIDE CREAM 1% - ANTIFUNGAL
gsk
LAMISILAT ® CREAM
Relieves Itching, Burning, Cracking and Scaling
NET WT 30 g (1 oz)
LAMISIL AT
terbinafine hydrochloride cream |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LAMISIL AT 77716475 3686080 Live/Registered |
Novartis AG 2009-04-17 |
LAMISIL AT 75638238 2466269 Live/Registered |
Novartis AG 1999-02-16 |